Features | Partner Sites | Information | LinkXpress
Sign In
FOCUS DIAGNOSTICS, INC.
Biostrata Ltd on behalf of Thermo
PURITAN MEDICAL

Industry News

Image: In a new collaboration, Abbott will be the exclusive distributor of Sekisui\'s new CP3000 coagulation instrument in various regions, enabling Abbott to provide coagulation testing solutions with the CP3000, a high-throughput system with a compact footprint (Image courtesy of Abbott).

Partnership to Offer New Coagulation Testing Solutions Worldwide

Abbott and Sekisui Diagnostics, a sister company of Sekisui Medical, have entered an agreement to offer new coagulation testing solutions for clinical labs to help better assess patient risk of excessive bleeding, developing clots, and other conditions.   More...
27 Apr 2015

Clinical Lab Automation Sector at USD 5.4 Billion and Growing

Lab automation systems sold to clinical laboratories reached USD 5.4 billion in sales in 2014. Shortage of personnel will further drive these purchases, as will a need for new systems, according to a new market research report on the status of lab automation in both clinical and drug-discovery lab segments.   More...
21 Apr 2015
77 ELEKTRONIKA
KARL HECHT GMBH & CO KG
CELLAVISION AB

Beyond Brazil, Latin American IVD Sector Grows

A new healthcare market analysis finds that in addition to Brazil, there are smaller countries in Latin America that are also top targets for in vitro diagnostics firms as their IVD sectors are projected to grow at faster rates.  More...
20 Apr 2015

Improved Ebola IVD Tests Continue to Face Challenges

A new Ebolavirus test provides significant advantage over the current diagnostic pathway, yet there is little justification to establish permanent, advanced testing at expense of more pressing needs  More...
14 Apr 2015

NanoString and MD Anderson Collaborate on Development of Novel Multi-Omic Expression Profiling Assays for Cancer

The University of Texas MD Anderson Cancer Center and NanoString Technologies will partner on development of a revolutionary new type of assay—simultaneously profiling gene and protein expression, initially aiming to discover and validate biomarker signatures for immuno-oncology and to extend targeted therapeutics programs.  More...
14 Apr 2015
Image: Under a new partnership, inactivated viruses from Microbix Biosystems, Inc. will be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets (Photo courtesy of Microbiologics).

Microbiologics and Microbix Partner on Viral Controls for Diagnostics

Microbiologics has entered into an agreement to source inactivated viruses from Microbix Biosystems to be incorporated into a line of full process controls under Microbiologics’ Helix Elite Molecular Standards brand as well as instrument-specific quality control sets.  More...
13 Apr 2015

Precision Makes dPCR a Steadily Growing Sector

Kalorama Information has estimated that the budding market for digital PCR reached USD 175 million in 2014 and anticipated growth to provide products for research and diagnostics in diseases like cancer and neurological disorders.   More...
07 Apr 2015


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.
 
Copyright © 2000-2015 Globetech Media. All rights reserved.